720 results on '"Rosato, Edoardo"'
Search Results
2. Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis
3. Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients
4. When pulmonary arterial hypertension complicates connective tissue diseases: we still have not found what we are looking for
5. Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward
6. Type 2 cytokines and scleroderma interstitial lung disease
7. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis
8. Thymic stromal lymphopoietin and digital microvascular damage in systemic sclerosis patients: A pilot study
9. Nephroangiosclerosis not related to hypertension: A matter to resolve in the era of precision medicine
10. Role of kinurenic acid in the systemic sclerosis renal involvement
11. Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
12. In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET
13. Changes in renal microcirculation in patients with nephrotic and nephritic syndrome: The role of resistive index
14. Serum-soluble ST2 and systemic sclerosis arthropathy
15. GLIM-diagnosed malnutrition predicts mortality and risk of hospitalization in systemic sclerosis: A retrospective study
16. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
17. In acromegalic patients the serum levels of interleukin-33 and Resolvin D1 influence skin perfusion of hands: A pilot study
18. Serum kynurenic acid is lower in systemic sclerosis patients with microvascular damage of hands
19. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
20. Phase angle, nutritional status, and mortality in systemic sclerosis: An exploratory pilot study
21. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
22. Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
23. Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
24. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients
25. #2421 Kidney injury in scleroderma: serum level of fibroblast growth factor-23, klotho and neutrophil gelatinase-associated lipocalin after iloprost infusion
26. Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis
27. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
28. Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy
29. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature
30. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology
31. Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease: the role of resistive index
32. Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients
33. IL33 and sST2 serum level in systemic sclerosis microvascular involvement
34. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.
35. Reciprocal effects of scleroderma and temporomandibular dysfunction between patient cohorts.
36. Color Doppler Ultrasonography of digital arteries and digital ulcers development in systemic sclerosis
37. Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
38. Prediction and primary prevention of major vascular complications in systemic sclerosis
39. Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis
40. Renal resistive index in IgA nephropathy and renal scleroderma vasculopathy
41. Does the impact of COVID-19 on patients with systemic sclerosis change over time?
42. Phase angle could be a marker of microvascular damage in systemic sclerosis
43. CD21low B cells in systemic sclerosis: A possible marker of vascular complications
44. Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study
45. Changes in renal microcirculation in patients with nephrotic and nephritic syndrome: The role of resistive index
46. Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
47. Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients
48. Comparisons of skin microvascular changes in patients with primary aldosteronism and essential hypertension
49. The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs
50. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.